Emergent BioSolutions Reports Second Quarter and Six Months 2017 Financial Results; Reaffirms Calendar Year 2017 Guidance

Go back to Emergent BioSolutions Reports Second Quarter and Six Months 2017 Financial Results; Reaffirms Calendar Year 2017 Guidance
EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) Delayed: 6.80 -0.22 (3.13%)
Previous Close $7.02    52 Week High $44.38 
Open $6.98    52 Week Low $24.47 
Day High $7.05    P/E 340.00 
Day Low $6.77    EPS $0.02 
Volume 1,874,482